Page last updated: 2024-08-23

idarubicin and Fetal Growth Restriction

idarubicin has been researched along with Fetal Growth Restriction in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Austin, N; Bayston, K; Carradice, D; Ganly, PS	1
Claahsen, HL; Mattijssen, V; Semmekrot, BA; van Dongen, PW	1

Other Studies

2 other study(ies) available for idarubicin and Fetal Growth Restriction

Article	Year
Successful treatment of acute promyelocytic leukaemia during pregnancy. Clinical and laboratory haematology, 2002, Volume: 24, Issue:5 Topics: Adolescent; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cesarean Section; Dexamethasone; Diuretics; Epilepsy, Tonic-Clonic; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Lung; Neutropenia; Nutrition Disorders; Oxygen; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Remission Induction; Respiration Disorders; Tranexamic Acid; Tretinoin	2002
Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report. American journal of perinatology, 1998, Volume: 15, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Infant, Premature; Leukemia, Monocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prenatal Exposure Delayed Effects	1998

Article

Year

Successful treatment of acute promyelocytic leukaemia during pregnancy.

Clinical and laboratory haematology, 2002, Volume: 24, Issue:5

Topics: Adolescent; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cesarean Section; Dexamethasone; Diuretics; Epilepsy, Tonic-Clonic; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Lung; Neutropenia; Nutrition Disorders; Oxygen; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Remission Induction; Respiration Disorders; Tranexamic Acid; Tretinoin

2002

Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report.

American journal of perinatology, 1998, Volume: 15, Issue:5

Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Infant, Premature; Leukemia, Monocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prenatal Exposure Delayed Effects

1998